aTYR PHARMA (ATYR) Capital Leases (2022 - 2026)
aTYR PHARMA's Capital Leases was $36,000 in Q2 2026, down 94.0% from $602,000 a year earlier and down 76.2% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Capital Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Capital Leases at aTYR PHARMA came in at $259,000, down 70.8% from FY2024.
- Capital Leases shows a three-year compound annual growth rate of -36.4% (FY2022 to FY2025).
- In earlier years, Capital Leases was $887,000 in FY2024 (-37.9%), $1.43 million in FY2023 (+41.8%) and $1.01 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Capital Leases in data going back to Q2 2022.
- Compared with a year earlier, Capital Leases has declined for ten straight quarters, with an average decline of 57.9% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was Q2 2023 (growth of 411.7%); the worst was Q2 2026 (a decline of 94.0%).
- Per Business Quant data, ATYR's Capital Leases in the three quarters before Q2 2026 was $151,000 (Q1 2026), $259,000 (Q4 2025) and $398,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Jun 30, 2025 | 602,000.00 |
| Mar 31, 2025 | 747,000.00 |
| Dec 31, 2024 | 887,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 618,000.00 |
| Jun 30, 2022 | 298,000.00 |
API Access
aTYR PHARMA Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();